HealthCare professionals across Europe are losing hours every day to administrative work. Searching patient records, drafting consult notes, chasing clinical guidelines, these tasks pull doctors and nurses away from patients. Delphyr, a Netherlands-based startup, is building an AI platform for HealthCare professionals that directly addresses this problem, and it just closed a €1.75 million funding round to scale it.
The round closed in early March 2026 and includes backing from notable investors such as the founders of Hugging Face and DEGIRO. That investor profile signals genuine confidence in both the technical approach and the market timing.
Built by a Doctor, for Doctors:
Michel Abdel Malek, CEO and founder of Delphyr, is also a practicing anesthesiologist. He built the platform from direct experience with the problem. Doctors in many European HealthCare systems spend a significant portion of their working hours on administrative tasks rather than direct patient care. That is a well-documented issue across primary care, hospitals, and mental HealthCare settings.
Malek’s background gives the product direction a credibility that many HealthCare AI tools lack. The design decisions at Delphyr reflect clinical priorities rather than generic enterprise software thinking.
The AI Platform for Healthcare:
Delphyr integrates directly into existing HealthCare systems. Professionals do not need to replace their current tools or learn new software. The platform sits as an intelligent layer on top of what is already in place.
The core capabilities include consolidating patient data from notes, lab results, and correspondence into a single summary view. It also surfaces relevant clinical guidelines on demand and supports drafting responses for correspondence and e-consults. One of the more practically useful features is ambient listening, which captures consultations and automatically converts them into structured clinical notes that link directly to the patient record.
For medical professionals already using HealthCare AI tools in their daily workflows, this kind of EHR-integrated automation is increasingly familiar. But Delphyr’s focus on European infrastructure and data residency is a meaningful technical distinction.
Privacy and Infrastructure:
All patient data is processed exclusively within the practice environment. The platform runs on secure European infrastructure, which matters considerably for HealthCare organizations operating under GDPR and local health data regulations.
This approach also removes a common adoption barrier. Many European HealthCare institutions have been cautious about cloud-based AI clinical documentation tools precisely because of data residency concerns. Delphyr’s infrastructure model is designed to work within those constraints from the start. For teams evaluating AI-powered clinical documentation solutions, this is a practical consideration worth noting.
Where the Funding Goes:
The €1.75 million will go toward further development of Delphyr’s AI agents and expanding access across HealthCare settings including hospitals, primary care practices, and mental HealthCare. The company is based in Amsterdam and is already available for use.
For startup founders building in HealthCare AI, Delphyr is a useful reference point for how to approach a regulated, trust-sensitive market. The product-led focus on immediate usability, with no system replacement required and no onboarding complexity, reflects a practical go-to-market logic for enterprise HealthCare sales.
For anyone following AI-driven clinical workflow automation or the broader European HealthTech market, Delphyr’s progress after this seed round is a practical example to follow.
